| 1 |
32691010 | CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation. | 2020 Sep 25 |
7 |
| 2 |
30504836 | Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization. | 2018 Nov 30 |
1 |
| 3 |
28318328 | Estrogen induces CXCR4 overexpression and CXCR4/CXL12 pathway activation in lung adenocarcinoma cells in vitro. | 2017 Aug |
2 |
| 4 |
26251419 | Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy. | 2015 Oct |
1 |
| 5 |
25237365 | The Effects of Tamoxifen in Combination with Tranilast on CXCL12-CXCR4 Axis and Invasion in Breast Cancer Cell Lines. | 2014 Spring |
3 |
| 6 |
22644306 | CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling. | 2012 Jun 26 |
3 |
| 7 |
19019622 | Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells. | 2009 Sep |
7 |
| 8 |
17362937 | Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells. | 2007 Apr 3 |
3 |